Kurosawa M
First Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.
Arzneimittelforschung. 1990 Feb;40(2 Pt 1):162-5.
Rat mast cells purified on a Percoll gradient were challenged with compound 48/80 and protein kinase C activity in the cell pellets and the amount of histamine release into the supernatant was assayed by measuring the incorporation of 32P from [gamma 32P]ATP (adenosine triphosphate) into lysine-rich histone and by the fluorometric technique, respectively. In another series of experiments, rat mast cell granules were isolated in a gradient from sonicated rat mast cells and diphosphoinositide kinase activity was assayed by measuring the incorporation of 32P from [gamma 32P]ATP into triphosphoinositide on oxalic acid-impregnated silica gel plates after the extraction of lipids in acidic condition. Azelastine (A-5610, E-0659) inhibited the histamine release from the cells in parallel with the tendency to inhibit the increased protein kinase C activity in the activated mast cells. Azelastine also inhibited the diphosphoinositide kinase activity in the granules. These inhibitory effects of azelastine on the phosphorylation enzymes in rat mast cells may be involved in the inhibitory mechanism of the mediator release from the cells.
用Percoll梯度纯化的大鼠肥大细胞用化合物48/80进行刺激,分别通过测量[γ-32P]ATP(三磷酸腺苷)中的32P掺入富含赖氨酸的组蛋白以及采用荧光测定技术,来检测细胞沉淀中的蛋白激酶C活性和释放到上清液中的组胺量。在另一系列实验中,从经超声处理的大鼠肥大细胞中通过梯度分离出大鼠肥大细胞颗粒,并在酸性条件下提取脂质后,通过测量[γ-32P]ATP中的32P掺入草酸浸渍硅胶板上的三磷酸肌醇来检测二磷酸肌醇激酶活性。氮卓斯汀(A-5610,E-0659)抑制细胞释放组胺,同时也倾向于抑制活化肥大细胞中蛋白激酶C活性的增加。氮卓斯汀还抑制颗粒中的二磷酸肌醇激酶活性。氮卓斯汀对大鼠肥大细胞中磷酸化酶的这些抑制作用可能参与了细胞中介质释放的抑制机制。